AVITA Medical Inc
NASDAQ:RCEL

Watchlist Manager
AVITA Medical Inc Logo
AVITA Medical Inc
NASDAQ:RCEL
Watchlist
Price: 11.77 USD 2.53% Market Closed
Market Cap: 308.6m USD
Have any thoughts about
AVITA Medical Inc?
Write Note

Wall Street
Price Targets

RCEL Price Targets Summary
AVITA Medical Inc

Wall Street analysts forecast RCEL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCEL is 17.34 USD with a low forecast of 12.12 USD and a high forecast of 22.05 USD.

Lowest
Price Target
12.12 USD
3% Upside
Average
Price Target
17.34 USD
47% Upside
Highest
Price Target
22.05 USD
87% Upside

RCEL Last Price Targets
AVITA Medical Inc

The latest public price target was made on May 14, 2024 by Matt O'Brien from Piper Sandler , who expects RCEL stock to drop by 24% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Matt O'Brien
Piper Sandler
9 USD
Downside 24%
7 months ago
May 14, 2024
Piper Sandler Downgrades Avita Medical Ltd. (RCEL) to Neutral
StreetInsider
Matt O'Brien
Piper Sandler
Price Target 9 USD
Upside/Downside 24%
View Source
AVITA Medical Inc Competitors:
Price Targets
STOK
Stoke Therapeutics Inc
95% Upside
NBIX
Neurocrine Biosciences Inc
23% Upside
068270
Celltrion Inc
30% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
17% Upside
7774
Japan Tissue Engineering Co Ltd
172% Upside
2162
KeyMed Biosciences Inc
87% Upside
BEAM
Beam Therapeutics Inc
73% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
26% Upside

Revenue
Forecast

Revenue Estimate
AVITA Medical Inc

For the last 1 year the compound annual growth rate for AVITA Medical Inc's revenue is 46%. The projected CAGR for the next 4 years is 29%.

46%
Past Growth
29%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
AVITA Medical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
AVITA Medical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RCEL's stock price target?
Price Target
17.34 USD

According to Wall Street analysts, the average 1-year price target for RCEL is 17.34 USD with a low forecast of 12.12 USD and a high forecast of 22.05 USD.

What is AVITA Medical Inc's Revenue forecast?
Projected CAGR
29%

For the last 1 year the compound annual growth rate for AVITA Medical Inc's revenue is 46%. The projected CAGR for the next 4 years is 29%.

Back to Top